236 related articles for article (PubMed ID: 26797372)
21. Do 18F-FDG PET/CT parameters in oropharyngeal and oral cavity squamous cell carcinomas indicate HPV status?
Kendi AT; Magliocca K; Corey A; Nickleach DC; Galt J; Higgins K; Beitler JJ; El-Deiry MW; Wadsworth JT; Hudgins PA; Saba NF; Schuster DM
Clin Nucl Med; 2015 Mar; 40(3):e196-200. PubMed ID: 25608156
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of tumor proliferation using dynamic contrast enhanced-MRI of oral cavity and oropharyngeal squamous cell carcinoma.
Konouchi H; Asaumi Ji; Yanagi Y; Shigehara H; Hisatomi M; Matsuzaki H; Kishi K
Oral Oncol; 2003 Apr; 39(3):290-5. PubMed ID: 12618202
[TBL] [Abstract][Full Text] [Related]
23. Application of whole-lesion histogram analysis of pharmacokinetic parameters in dynamic contrast-enhanced MRI of breast lesions with the CAIPIRINHA-Dixon-TWIST-VIBE technique.
Li Z; Ai T; Hu Y; Yan X; Nickel MD; Xu X; Xia L
J Magn Reson Imaging; 2018 Jan; 47(1):91-96. PubMed ID: 28577335
[TBL] [Abstract][Full Text] [Related]
24. Differences in survival outcome between oropharyngeal and oral cavity squamous cell carcinoma in relation to HPV status.
Lai K; Killingsworth M; Matthews S; Caixeiro N; Evangelista C; Wu X; Wykes J; Samakeh A; Forstner D; Niles N; Hong A; Lee CS
J Oral Pathol Med; 2017 Sep; 46(8):574-582. PubMed ID: 27935119
[TBL] [Abstract][Full Text] [Related]
25. Clinical utility of multimodality imaging with dynamic contrast-enhanced MRI, diffusion-weighted MRI, and 18F-FDG PET/CT for the prediction of neck control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.
Ng SH; Lin CY; Chan SC; Lin YC; Yen TC; Liao CT; Chang JT; Ko SF; Wang HM; Chang CJ; Wang JJ
PLoS One; 2014; 9(12):e115933. PubMed ID: 25531391
[TBL] [Abstract][Full Text] [Related]
26. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor.
Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B
Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236
[TBL] [Abstract][Full Text] [Related]
27. Human papillomavirus infection in oral squamous cell carcinomas from Chilean patients.
Reyes M; Rojas-Alcayaga G; Pennacchiotti G; Carrillo D; Muñoz JP; Peña N; Montes R; Lobos N; Aguayo F
Exp Mol Pathol; 2015 Aug; 99(1):95-9. PubMed ID: 26057833
[TBL] [Abstract][Full Text] [Related]
28. Correlation of MRI quantitative perfusion parameters with EGFR, VEGF and EGFR gene mutations in non-small cell cancer.
Zou M; Zhang B; Shi L; Mao H; Huang Y; Zhao Z
Sci Rep; 2024 Feb; 14(1):4447. PubMed ID: 38396128
[TBL] [Abstract][Full Text] [Related]
29. Dynamic Contrast-enhanced MR Imaging Parameters in Bone Metastases from Non-Small Cell Lung Cancer: Comparison between Lesions with and Lesions without Epidermal Growth Factor Receptor Mutation in Primary Lung Cancer.
Kim HS; Yoon YC; Kwon S; Lee JH; Ahn S; Ahn HS
Radiology; 2017 Sep; 284(3):815-823. PubMed ID: 28448232
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx.
Ritchie JM; Smith EM; Summersgill KF; Hoffman HT; Wang D; Klussmann JP; Turek LP; Haugen TH
Int J Cancer; 2003 Apr; 104(3):336-44. PubMed ID: 12569557
[TBL] [Abstract][Full Text] [Related]
31. Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden.
Hansson BG; Rosenquist K; Antonsson A; Wennerberg J; Schildt EB; Bladström A; Andersson G
Acta Otolaryngol; 2005 Dec; 125(12):1337-44. PubMed ID: 16303684
[TBL] [Abstract][Full Text] [Related]
32. HPV-related Oropharyngeal Squamous Cell Carcinoma: p16INK4A Immunohistochemistry or HPV Genotyping?
Orsaria M; Marzinotto S; De Marchi L; Giacomarra V; Boria S; Rubini C; Londero AP; Di Loreto C; Mariuzzi L
Anticancer Res; 2015 Sep; 35(9):4733-9. PubMed ID: 26254363
[TBL] [Abstract][Full Text] [Related]
33. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx.
Śnietura M; Jaworska M; Pigłowski W; Goraj-Zając A; Woźniak G; Lange D
Pol J Pathol; 2010; 61(3):133-9. PubMed ID: 21225495
[TBL] [Abstract][Full Text] [Related]
34. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
Huang SH; Perez-Ordonez B; Liu FF; Waldron J; Ringash J; Irish J; Cummings B; Siu LL; Kim J; Weinreb I; Hope A; Gullane P; Brown D; Shi W; O'Sullivan B
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):276-83. PubMed ID: 20950953
[TBL] [Abstract][Full Text] [Related]
35. Whole-tumour histogram analysis of pharmacokinetic parameters from dynamic contrast-enhanced MRI in resectable oesophageal squamous cell carcinoma can predict T-stage and regional lymph node metastasis.
Chen YL; Li R; Chen TW; Ou J; Zhang XM; Chen F; Wu L; Jiang Y; Laws M; Shah K; Joseph B; Hu J
Eur J Radiol; 2019 Mar; 112():112-120. PubMed ID: 30777199
[TBL] [Abstract][Full Text] [Related]
36. HPV status and overall survival of patients with oropharyngeal squamous cell carcinoma--a retrospective study of a German head and neck cancer center.
Tahtali A; Hey C; Geissler C; Filman N; Diensthuber M; Leinung M; Stöver T; Wagenblast J
Anticancer Res; 2013 Aug; 33(8):3481-5. PubMed ID: 23898123
[TBL] [Abstract][Full Text] [Related]
37. Variable expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancer.
Um SH; Mundi N; Yoo J; Palma DA; Fung K; MacNeil D; Wehrli B; Mymryk JS; Barrett JW; Nichols AC
J Clin Virol; 2014 Sep; 61(1):94-100. PubMed ID: 25027574
[TBL] [Abstract][Full Text] [Related]
38. Effect of neoadjuvant chemotherapy and its correlation with HPV status, EGFR, Her-2-neu, and GADD45 expression in oral squamous cell carcinoma.
Pandey M; Kannepali KK; Dixit R; Kumar M
World J Surg Oncol; 2018 Jan; 16(1):20. PubMed ID: 29386013
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemistry Analysis of CD44, EGFR, and p16 in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
Cohen ER; Reis IM; Gomez C; Pereira L; Freiser ME; Hoosien G; Franzmann EJ
Otolaryngol Head Neck Surg; 2017 Aug; 157(2):239-251. PubMed ID: 28397583
[TBL] [Abstract][Full Text] [Related]
40. Impact of epidermal growth factor receptor, mesenchymal-epithelial transition factor, and insulin-like growth factor receptor 1 expression on survival of patients with oral and oropharyngeal cancer.
Perisanidis C; Wrba F; Brandstetter A; Kornek G; Mitchell D; Seemann R; Selzer E; Ewers R; Filipits M
Br J Oral Maxillofac Surg; 2013 Apr; 51(3):234-40. PubMed ID: 22889668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
